<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0"><channel><title>Silicon Valley Bank - Life Science</title><link>http://www.svb.com/feedburnerrss.aspx?id=4294979939&amp;type=publications</link><image><url>http://www.svb.com/images/logo-svb-color.png</url><title>Silicon Valley Bank</title><link>http://www.svb.com/feedburnerrss.aspx?id=4294979939&amp;type=publications</link></image><description>Latest Publication Updates for Silicon Valley Bank</description><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.feedburner.com/SVBFinancialGroup-LifeScience" /><feedburner:info uri="svbfinancialgroup-lifescience" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><feedburner:emailServiceId>SVBFinancialGroup-LifeScience</feedburner:emailServiceId><feedburner:feedburnerHostname>http://feedburner.google.com</feedburner:feedburnerHostname><feedburner:feedFlare href="http://add.my.yahoo.com/rss?url=http%3A%2F%2Ffeeds.feedburner.com%2FSVBFinancialGroup-LifeScience" src="http://us.i1.yimg.com/us.yimg.com/i/us/my/addtomyyahoo4.gif">Subscribe with My Yahoo!</feedburner:feedFlare><feedburner:feedFlare href="http://www.newsgator.com/ngs/subscriber/subext.aspx?url=http%3A%2F%2Ffeeds.feedburner.com%2FSVBFinancialGroup-LifeScience" src="http://www.newsgator.com/images/ngsub1.gif">Subscribe with NewsGator</feedburner:feedFlare><feedburner:feedFlare href="http://feeds.my.aol.com/add.jsp?url=http%3A%2F%2Ffeeds.feedburner.com%2FSVBFinancialGroup-LifeScience" src="http://o.aolcdn.com/favorites.my.aol.com/webmaster/ffclient/webroot/locale/en-US/images/myAOLButtonSmall.gif">Subscribe with My AOL</feedburner:feedFlare><feedburner:feedFlare href="http://www.bloglines.com/sub/http://feeds.feedburner.com/SVBFinancialGroup-LifeScience" src="http://www.bloglines.com/images/sub_modern11.gif">Subscribe with Bloglines</feedburner:feedFlare><feedburner:feedFlare href="http://www.netvibes.com/subscribe.php?url=http%3A%2F%2Ffeeds.feedburner.com%2FSVBFinancialGroup-LifeScience" src="http://www.netvibes.com/img/add2netvibes.gif">Subscribe with Netvibes</feedburner:feedFlare><feedburner:feedFlare href="http://fusion.google.com/add?feedurl=http%3A%2F%2Ffeeds.feedburner.com%2FSVBFinancialGroup-LifeScience" src="http://buttons.googlesyndication.com/fusion/add.gif">Subscribe with Google</feedburner:feedFlare><feedburner:feedFlare href="http://www.pageflakes.com/subscribe.aspx?url=http%3A%2F%2Ffeeds.feedburner.com%2FSVBFinancialGroup-LifeScience" src="http://www.pageflakes.com/ImageFile.ashx?instanceId=Static_4&amp;fileName=ATP_blu_91x17.gif">Subscribe with Pageflakes</feedburner:feedFlare><item><title>Halo Report 2012</title><author>Carrie Walsh</author><content:encoded><![CDATA[<table cellpadding="3"><tr><td align="center" valign="top"><img src="http://www.svb.com/uploadedimages/avatars/4294971686_u_CWSVB_Headshot(634637953869884146).jpg" width="108" /><br /><nobr><font size="1">Carrie Walsh</font></nobr></td><td valign="top">Through our partnership with the Angel Resource Institute and CB Insights, we are studying angel group investment activity to arm entrepreneurs and investors as they seek to better understand angel investing and jump start emerging businesses.&#160;&#160;<a href="http://www.svb.com/blogs/cwalsh/halo-report-2012/">Read More</a></td></tr></table>]]></content:encoded><link>http://feedproxy.google.com/~r/SVBFinancialGroup-LifeScience/~3/Btp_hca58ZE/</link><pubDate>Mon, 15 Apr 2013 22:56:20 GMT</pubDate><guid isPermaLink="false">10737423340</guid><feedburner:origLink>http://www.svb.com/blogs/cwalsh/halo-report-2012/</feedburner:origLink></item><item><title>Join Us: Immigration Reform &amp; The Issue of Talent</title><author>Greg Becker</author><content:encoded><![CDATA[<table cellpadding="3"><tr><td align="center" valign="top"><img src="http://www.svb.com/uploadedimages/avatars/thumb_4294968011_u_photo_gbecker.jpg" width="108" /><br /><nobr><font size="1">Greg Becker</font></nobr></td><td valign="top"><p>Finding, attracting and retaining world-class talent is increasingly difficult for many of Silicon Valley Bank’s technology and life science clients. In fact, our annual <a href="https://www.svb.com/startup-outlook-report/">Startup Outlook</a> survey revealed while nine in ten startup executives said they were hiring, an equal number said it is challenging – or extremely challenging – to find workers with the skills they need.</p>&#160;&#160;<a href="http://www.svb.com/Blogs/Greg_Becker/Join_Us__Immigration_Reform___The_Issue_of_Talent/">Read More</a></td></tr></table>]]></content:encoded><link>http://feedproxy.google.com/~r/SVBFinancialGroup-LifeScience/~3/D-40UEloD8Y/</link><pubDate>Fri, 08 Mar 2013 19:45:33 GMT</pubDate><guid isPermaLink="false">10737423063</guid><feedburner:origLink>http://www.svb.com/Blogs/Greg_Becker/Join_Us__Immigration_Reform___The_Issue_of_Talent/</feedburner:origLink></item><item><title>Startup Outlook 2013: The Issue of Talent, Tell Us Your Story</title><author>Greg Becker</author><content:encoded><![CDATA[<table cellpadding="3"><tr><td align="center" valign="top"><img src="http://www.svb.com/uploadedimages/avatars/thumb_4294968011_u_photo_gbecker.jpg" width="108" /><br /><nobr><font size="1">Greg Becker</font></nobr></td><td valign="top"><p>Every time I meet with a group of tech company CEOs they say the same thing: hiring world-class talent is one of their biggest challenges. They struggle to find, attract and retain the engineering, scientific and technical talent they need to grow their businesses.</p>
<p>So when I saw the results of our annual <a title="Startup Outlook survey " href="/startup-outlook-report/" target="_blank">Startup Outlook survey </a>this year, I was not surprised. While nine in ten startup executives said they were hiring, an equal number said it is challenging - or extremely challenging - to find workers with the skills they need.</p>&#160;&#160;<a href="http://www.svb.com/blogs/gbecker/startup-outlook-2013-immigration-reform/">Read More</a></td></tr></table>]]></content:encoded><link>http://feedproxy.google.com/~r/SVBFinancialGroup-LifeScience/~3/DRxh-m2gzhs/</link><pubDate>Wed, 13 Feb 2013 15:39:30 GMT</pubDate><guid isPermaLink="false">10737422924</guid><feedburner:origLink>http://www.svb.com/blogs/gbecker/startup-outlook-2013-immigration-reform/</feedburner:origLink></item><item><title>Startup Outlook 2013: Startups’ Advice to President Obama</title><author>Mary Dent</author><content:encoded><![CDATA[<table cellpadding="3"><tr><td align="center" valign="top"><img src="http://www.svb.com/uploadedimages/avatars/thumb_10098_u_mdent_sm.jpg" width="108" /><br /><nobr><font size="1">Mary Dent</font></nobr></td><td valign="top">Knowing the significance of innovation startups on the prospects for growth in the US economy overall, we starting asking leaders of startup companies about four years ago how their businesses are performing, whether they are hiring and which policies will continue to enable their growth.&#160;&#160;<a href="http://www.svb.com/blogs/mdent/startup-outlook-2013/">Read More</a></td></tr></table>]]></content:encoded><link>http://feedproxy.google.com/~r/SVBFinancialGroup-LifeScience/~3/qaDZniEmtM0/</link><pubDate>Thu, 17 Jan 2013 23:47:11 GMT</pubDate><guid isPermaLink="false">10737422728</guid><feedburner:origLink>http://www.svb.com/blogs/mdent/startup-outlook-2013/</feedburner:origLink></item><item><title>Startup Outlook 2012</title><author>Mary Dent</author><content:encoded><![CDATA[<table cellpadding="3"><tr><td align="center" valign="top"><img src="http://www.svb.com/uploadedimages/avatars/thumb_10098_u_mdent_sm.jpg" width="108" /><br /><nobr><font size="1">Mary Dent</font></nobr></td><td valign="top">The 2012 Startup Outlook Survey captures a U.S. economy in transition. The technology sector continues to lead the broader economy out of the downturn, posting strong returns even as the overall economy strains to rebound. Dynamicnew sectors are growing rapidly, businesses are hiring and startup executives are bullish on the U.S. market. Optimism and confidence remain high.&#160;&#160;<a href="http://www.svb.com/startup-outlook-2012/">Read More</a></td></tr></table>]]></content:encoded><link>http://feedproxy.google.com/~r/SVBFinancialGroup-LifeScience/~3/SGebvAoEI9k/</link><pubDate>Thu, 01 Nov 2012 16:55:00 GMT</pubDate><guid isPermaLink="false">10737418613</guid><feedburner:origLink>http://www.svb.com/startup-outlook-2012/</feedburner:origLink></item><item><title>Continued Rebound: Trends in Life Science M&amp;A</title><author>Jonathan Norris</author><content:encoded><![CDATA[<table cellpadding="3"><tr><td align="center" valign="top"><img src="http://www.svb.com/uploadedimages/avatars/thumb_4294968011_u_photo-jnorris.jpg" width="108" /><br /><nobr><font size="1">Jonathan Norris</font></nobr></td><td valign="top">Continued Rebound: Trends in Life Science M&amp;A" examines merger and acquisition trends for private, venture capital-backed biotech and medical device companies. The analysis of the data shows positive momentum in life science exits, positioning life science as an attractive investment opportunity now and in the future.&#160;&#160;<a href="http://www.svb.com/blogs/jnorris/ma-analysis-2012/">Read More</a></td></tr></table>]]></content:encoded><link>http://feedproxy.google.com/~r/SVBFinancialGroup-LifeScience/~3/UJuBb1e-TIw/</link><pubDate>Thu, 19 Jul 2012 12:00:00 GMT</pubDate><guid isPermaLink="false">10737419374</guid><feedburner:origLink>http://www.svb.com/blogs/jnorris/ma-analysis-2012/</feedburner:origLink></item><item><title>First Mover Advantage: The Case for Investing in Life Science</title><author>Jonathan Norris</author><content:encoded><![CDATA[<table cellpadding="3"><tr><td align="center" valign="top"><img src="http://www.svb.com/uploadedimages/avatars/thumb_4294968011_u_photo-jnorris.jpg" width="108" /><br /><nobr><font size="1">Jonathan Norris</font></nobr></td><td valign="top">&#160;&#160;<a href="http://www.svb.com/Blogs/Jonathan_Norris/First_Mover_Advantage__The_Case_for_Investing_in_Life_Science/">Read More</a></td></tr></table>]]></content:encoded><link>http://feedproxy.google.com/~r/SVBFinancialGroup-LifeScience/~3/oLlGnSmnFjs/</link><pubDate>Tue, 17 Jul 2012 04:05:00 GMT</pubDate><guid isPermaLink="false">10737419576</guid><feedburner:origLink>http://www.svb.com/Blogs/Jonathan_Norris/First_Mover_Advantage__The_Case_for_Investing_in_Life_Science/</feedburner:origLink></item><item><title>Webinar - Demystifying The Jobs Act: What It Means For Your Company</title><author>Marshall Hawks</author><content:encoded><![CDATA[<table cellpadding="3"><tr><td align="center" valign="top"><img src="http://www.svb.com/uploadedimages/avatars/thumb_4294968136_u_SVB Hawks-9290_web copy.jpg" width="108" /><br /><nobr><font size="1">Marshall Hawks</font></nobr></td><td valign="top"><p>Listen to our round table discussion of the JOBS Act and its implications for both early-stage and late-stage companies. Our panel, including Bill Hambrecht, discuss crowdfunding, the IPO on-ramp, and options for raising capital in this online webinar. </p>&#160;&#160;<a href="http://www.svb.com/webinar-jobs-act/">Read More</a></td></tr></table>]]></content:encoded><link>http://feedproxy.google.com/~r/SVBFinancialGroup-LifeScience/~3/ByrhRnwEHZc/</link><pubDate>Fri, 29 Jun 2012 22:05:00 GMT</pubDate><guid isPermaLink="false">10737419226</guid><feedburner:origLink>http://www.svb.com/webinar-jobs-act/</feedburner:origLink></item><item><title>SVB Showcase Videos: See Innovators Discuss their Ideas</title><author>Gerald Brady</author><content:encoded><![CDATA[<table cellpadding="3"><tr><td align="center" valign="top"><img src="http://www.svb.com/uploadedimages/avatars/thumb_4294968011_u_sm-gbrady.jpg" width="108" /><br /><nobr><font size="1">Gerald Brady</font></nobr></td><td valign="top">Some of the most exciting venture capitalists and entrepreneurs in the country and from around globe shared their new-business ideas for technology, life science and cleantech in the latest Silicon Valley Bank SVB Showcase.&#160;&#160;<a href="http://www.svb.com/blogs/gbrady/showcase-videos-2011/">Read More</a></td></tr></table>]]></content:encoded><link>http://feedproxy.google.com/~r/SVBFinancialGroup-LifeScience/~3/D04gfMj31t0/</link><pubDate>Wed, 16 Nov 2011 00:45:00 GMT</pubDate><guid isPermaLink="false">4294974131</guid><feedburner:origLink>http://www.svb.com/blogs/gbrady/showcase-videos-2011/</feedburner:origLink></item><item><title>Private Life Science M&amp;A Analysis: More Structured deals and quicker exits in Biotech</title><author>Jonathan Norris</author><content:encoded><![CDATA[<table cellpadding="3"><tr><td align="center" valign="top"><img src="http://www.svb.com/uploadedimages/avatars/thumb_4294968011_u_photo-jnorris.jpg" width="108" /><br /><nobr><font size="1">Jonathan Norris</font></nobr></td><td valign="top">Having worked with life science companies for many years, we recognized that 
the M&amp;A data that was available in the market was too inclusive. We started 
looking at the data ourselves, in a slightly different way and discovered some 
really interesting findings that surprised us.&#160;&#160;<a href="http://www.svb.com/blogs/jnorris/ma-analysis-2011/">Read More</a></td></tr></table>]]></content:encoded><link>http://feedproxy.google.com/~r/SVBFinancialGroup-LifeScience/~3/CUG3j9UBnpw/</link><pubDate>Wed, 18 May 2011 21:52:02 GMT</pubDate><guid isPermaLink="false">4294972488</guid><feedburner:origLink>http://www.svb.com/blogs/jnorris/ma-analysis-2011/</feedburner:origLink></item><item><title>Online Seminar: The Health of Biopharma - Trends in Investments and Exits</title><author>Ashraf Hebela, CFA</author><content:encoded><![CDATA[<table cellpadding="3"><tr><td align="center" valign="top"><img src="http://www.svb.com/uploadedimages/avatars/thumb_4294968136_u_A_Hebela_0511.jpg" width="108" /><br /><nobr><font size="1">Ashraf Hebela, CFA</font></nobr></td><td valign="top">Join our panel of experts on biopharma valuations and venture capital investment in this Web seminar as they discuss the results of SVB Analytics’ latest research findings, including operating performance, venture funding and valuations, and exit activity ...&#160;&#160;<a href="http://www.svb.com/webinar/trends-in-investments-exits/">Read More</a></td></tr></table>]]></content:encoded><link>http://feedproxy.google.com/~r/SVBFinancialGroup-LifeScience/~3/09ExeakbNPA/</link><pubDate>Mon, 09 May 2011 17:50:51 GMT</pubDate><guid isPermaLink="false">4294972440</guid><feedburner:origLink>http://www.svb.com/webinar/trends-in-investments-exits/</feedburner:origLink></item><item><title>Medical Device Investing: Time to Challenge the Conventional Wisdom</title><author>Michael Hanewich</author><content:encoded><![CDATA[<table cellpadding="3"><tr><td align="center" valign="top"><img src="http://www.svb.com/uploadedimages/avatars/thumb_10017_u__MG_0642_192px.jpg" width="108" /><br /><nobr><font size="1">Michael Hanewich</font></nobr></td><td valign="top">A new analysis questions the assumption that bets in medtech companies pay off more quickly and surely than biopharma investments. However, when medical device companies win, they win big ...&#160;&#160;<a href="http://www.svb.com/Blogs/Michael_Hanewich/Medical_Device_Investing__Time_to_Challenge_the_Conventional_Wisdom/">Read More</a></td></tr></table>]]></content:encoded><link>http://feedproxy.google.com/~r/SVBFinancialGroup-LifeScience/~3/Mr2x5_cPQa4/</link><pubDate>Sat, 05 Feb 2011 00:36:19 GMT</pubDate><guid isPermaLink="false">4294971771</guid><feedburner:origLink>http://www.svb.com/Blogs/Michael_Hanewich/Medical_Device_Investing__Time_to_Challenge_the_Conventional_Wisdom/</feedburner:origLink></item><item><title>Video: What Entrepreneurs and VCs are Saying</title><author>Lafe Vittitoe</author><content:encoded><![CDATA[<table cellpadding="3"><tr><td align="center" valign="top"><img src="http://www.svb.com/uploadedimages/avatars/10087_u_237e3de(634680353092421320).jpg" width="108" /><br /><nobr><font size="1">Lafe Vittitoe</font></nobr></td><td valign="top">Venture capitalists and startup company executives who attended the latest Silicon Valley Bank SVB Showcase event were generally upbeat about prospects for  technology, life science and cleantech innovation and investment. The quarterly invitation-only pitch event brought together dozens of people from early and growth stage companies seeking to raise their next round of funding, and from venture capitalist firms.&#160;&#160;<a href="http://www.svb.com/blogs/lvittitoe/entrepreneurs_vcs_saying/">Read More</a></td></tr></table>]]></content:encoded><link>http://feedproxy.google.com/~r/SVBFinancialGroup-LifeScience/~3/aov2pJOzwaI/</link><pubDate>Mon, 08 Nov 2010 23:08:58 GMT</pubDate><guid isPermaLink="false">4294970845</guid><feedburner:origLink>http://www.svb.com/blogs/lvittitoe/entrepreneurs_vcs_saying/</feedburner:origLink></item><item><title>Under the Microscope: Trends in Life Science Investments and Exits Online Seminar</title><author>Dave Krimm</author><content:encoded><![CDATA[<table cellpadding="3"><tr><td align="center" valign="top"><img src="http://www.svb.com/images/icon_192x192.gif" width="108" /><br /><nobr><font size="1">Dave Krimm</font></nobr></td><td valign="top">SVB Analytics' Web seminar focuses on trends in the Life Science sector, including venture capital financing, M&amp;A, and IPO activity.  In this free replay of the seminar, you will hear a variety of viewpoints from our expert panel of venture capitalists who have investment experience in the Life Science sector, as well as valuation and research professionals from SVB.&#160;&#160;<a href="http://www.svb.com/Blogs/Dave_Krimm/Under_the_Microscope__Trends_in_Life_Science_Investments_and_Exits_Online_Seminar/">Read More</a></td></tr></table>]]></content:encoded><link>http://feedproxy.google.com/~r/SVBFinancialGroup-LifeScience/~3/yXHoqohg72A/</link><pubDate>Fri, 08 Oct 2010 19:10:00 GMT</pubDate><guid isPermaLink="false">4294969907</guid><feedburner:origLink>http://www.svb.com/Blogs/Dave_Krimm/Under_the_Microscope__Trends_in_Life_Science_Investments_and_Exits_Online_Seminar/</feedburner:origLink></item><item><title>Bringing Home the Bacon: A Look at Recent Life Science Exit Data</title><author>Jonathan Norris</author><content:encoded><![CDATA[<table cellpadding="3"><tr><td align="center" valign="top"><img src="http://www.svb.com/uploadedimages/avatars/thumb_4294968011_u_photo-jnorris.jpg" width="108" /><br /><nobr><font size="1">Jonathan Norris</font></nobr></td><td valign="top"><p>Have you wondered how many really good life science M&amp;A exits happen every year? Are the big guys even buying? Do these exits actually provide returns that materially affect the venture funds that are investing?</p>&#160;&#160;<a href="http://www.svb.com/Blogs/Jonathan_Norris/Bringing_Home_the_Bacon__A_Look_at_Recent_Life_Science_Exit_Data/">Read More</a></td></tr></table>]]></content:encoded><link>http://feedproxy.google.com/~r/SVBFinancialGroup-LifeScience/~3/Xxc2RkH7nl8/</link><pubDate>Fri, 03 Sep 2010 23:51:58 GMT</pubDate><guid isPermaLink="false">4294969884</guid><feedburner:origLink>http://www.svb.com/Blogs/Jonathan_Norris/Bringing_Home_the_Bacon__A_Look_at_Recent_Life_Science_Exit_Data/</feedburner:origLink></item><item><title>Video: How Venture Capital Works</title><author>Michael Hanewich</author><content:encoded><![CDATA[<table cellpadding="3"><tr><td align="center" valign="top"><img src="http://www.svb.com/uploadedimages/avatars/thumb_10017_u__MG_0642_192px.jpg" width="108" /><br /><nobr><font size="1">Michael Hanewich</font></nobr></td><td valign="top"><p>Silicon Valley Bank’s Michael Hanewich, head of life sciences on the East Coast, leads an hour long conversation between entrepreneur John Mendlein, chairman of Fate Therapeutics and former CEO of Adnexus (acquired by Bristol Myers Squibb in 2007 for more</p>&#160;&#160;<a href="http://www.svb.com/Blogs/Michael_Hanewich/Video__How_Venture_Capital_Works/">Read More</a></td></tr></table>]]></content:encoded><link>http://feedproxy.google.com/~r/SVBFinancialGroup-LifeScience/~3/yfrcVaowotM/</link><pubDate>Fri, 05 Feb 2010 01:02:39 GMT</pubDate><guid isPermaLink="false">4294967472</guid><feedburner:origLink>http://www.svb.com/Blogs/Michael_Hanewich/Video__How_Venture_Capital_Works/</feedburner:origLink></item></channel></rss>
